Based on previous findings, we concluded that HOXA9 gene methylation and the CNV of SOX2 and HV2 genes in cfDNA could be used in a single panel for non-invasive diagnosis of NSCLC with high sensitivity and specificity. The gene discussed is HOXA9; the disease is non-small cell lung carcinoma.